Mechanisms of Disease: Update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 5, 2007, Pages 277-287

  Carter, Beth A ^a   Shulman, Robert J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; AMINOTRANSFERASE; ANTIBIOTIC AGENT; BILIRUBIN; ENDOTOXIN; LIPID; MANGANESE; METRONIDAZOLE; OXIDIZING AGENT; TAURINE; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; BLOOD CLOTTING DISORDER; CHOLESTASIS; CLINICAL PRACTICE; DEATH; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFICACY; ENTERIC FEEDING; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; NUTRITIONAL DEFICIENCY; PARENTERAL NUTRITION; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; SEPSIS; SHORT BOWEL SYNDROME;

ANIMALS; CHOLESTASIS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEDICAL RECORDS; PARENTERAL NUTRITION;

EID: 34248199431     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0796     Document Type: Review

References (86)

1. Rhoads JE (2001) The development of TPN: An interview with pioneer surgical nutritionist Jonathan E Rhoads, MD [Interview by Carolyn T Spencer and Charlene Compher]. J Am Diet Assoc 101: 747-750
2. Guenter P et al. (2004) The impact of nursing practice on the history and effectiveness of total parenteral nutrition. JPEN J Parenter Enteral Nutr 28: 54-59
3. [No authors listed] (1981) Nutrition classics. Surgery, Volume 64, 1968. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance: Stanley J. Dudrick, Douglas W. Wilmore, Harry M. Vars, Jonathan E. Rhoads. Nutr Rev 39: 278-281
4. Rager R and Finegold MJ (1975) Cholestasis in immature newborn infants: is parenteral alimentation responsible? J Pediatr 86: 264-269
5. Finegold MJ (1982) Total parenteral alimentation and cholestasis. Am J Clin Pathol 77: 378-379
6. Drongowski RA and Coran AG (1989) An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 13: 586-589
7. Sokol RJ (1997) Total parenteral nutrition-related liver disease. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 38: 418-428
8. Kelly DA (1998) Liver complications of pediatric parenteral nutrition - epidemiology. Nutrition 14: 153-157
9. Teitelbaum DH (1997) Parenteral nutrition-associated cholestasis. Curr Opin Pediatr 9: 270-275
10. Kelly DA (2006) Intestinal failure-associated liver disease: What do we know today? Gastroenterology 130 (Suppl 1): S70-S77
11. Beale EF et al. (1979) Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 64: 342-347
12. Btaiche IF and Khalidi N (2002) Parenteral nutrition-associated liver complications in children. Pharmacotherapy 22: 188-211
13. Beath SV et al. (1996) Parenteral nutrition-related cholestasis in postsurgical neonates: Multivariate analysis of risk factors. J Pediatr Surg 31: 604-606
14. Zambrano E et al. (2004) Total parenteral nutrition induced liver pathology: An autopsy series of 24 newborn cases. Pediatr Dev Pathol 7: 425-432
15. Mullick FG et al. (1994) Total parenteral nutrition: A histopathologic analysis of the liver changes in 20 children. Mod Pathol 7: 190-194
16. Cohen C and Olsen MM (1981) Pediatric total parenteral nutrition: Liver histopathology. Arch Pathol Lab Med 105: 152-156
17. Colomb V et al. (1992) Long-term parenteral nutrition in children: liver and gallbladder disease. Transplant Proc 24: 1054-1055
18. Shulman RJ (2000) New developments in total parenteral nutrition for children. Curr Gastroenterol Rep 2: 253-258
19. Bell RL et al. (1986) Total parenteral nutrition-related cholestasis in infants. JPEN J Parenter Enteral Nutr 10: 356-359
20. Balistreri WF et al. (1983) Immaturity of the enterohepatic circulation in early life: Factors predisposing to "physiologic" maldigestion and cholestasis. J Pediatr Gastroenterol Nutr 2 346-354
21. Lester R et al. (1983) Diversity of bile acids in the fetus and newborn infant. J Pediatr Gastroenterol Nutr 2: 355-364
22. de Belle RC et al. (1979) Intestinal absorption of bile selts: immature development in the neonate. J Pediatr 94: 472-476
23. Denehy CM and Ryan JR (1986) Development of gallbladder contractility in the guinea pig. Pediatr Res 20: 214-217
24. +-ATPase activity in fetal and neonatal rat liver plasma membrane vesicles. Am J Physiol 251: 665-673
25. Karpen SJ (2002) Nuclear receptor regulation of hepatic function. J Hepatol 36: 832-850
26. Zollner G et al. (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations. Mol Pharm 3: 231-251
27. Gao B et al. (2004) Differential expression of bile salt and organic anion transporters in developing rat liver. J Hapatol 41: 201-208
28. Chen HL et al. (2004) Developmental expression of canalicular transporter genes in human liver [abstract]. J Pediatr Gastroenterol Nutr. 39 (Suppl): AS68
29. Chen HL et al. (2005) Developmental expression of canalicular transporter genes in human liver. J Hepatol 43: 472-477
30. Touloukian RJ and Seashore JH (1975) Hepatic secretory obstruction with total parenteral nutrition in the infant. J Pediatr Surg 10: 353-360
31. Aynsley-Green A (1983) Plasma hormone concentrations during enteral and parenteral nutrition in the human newborn. J Pediatr Gastroenterol Nutr 2 (Suppi 1): S108-S112
32. Aynsley-Green A (1989) The endocrinology of feeding in the newborn. Baillieres Clin Endocrinol Metab 3: 837-868
33. Lucas A et al. (1983) Metabolic and endocrine consequences of depriving preterm infants of enteral nutrition. Acta Paediatr Scand 72: 245-249
34. Fedorowski T et al. (1979) Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology 77: 1068-1073
35. Lichtman SN et al. (1990) Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 98: 414-423
36. Lichtman SN et al. (1991) Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 13 766-772
37. Lichtman SN et al. (1991) Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100: 513-519
38. Freund HR et al. (1985) A possible beneficial effect of metronidazole in reducing TPN-associated liver function derangements. J Surg Res 38: 356-363
39. Nanji AA and Anderson FH (1984) Cholestasis associated with parenteral nutrition develops more commonly with hematologic malignancy than with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 8: 325
40. Fouin-Fortunet H et al. (1982) Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: A possible consequence of lithocholate toxicity. Gastroenterology 82: 932-937
41. Cruccetti A et al. (2003) Surgical infants on total parenteral nutrition have impaired cytokine responses to microbial challenge. J Pediatr Surg 38: 138-142
42. Zheng YJ et al. (2004) Endotoxin and cytokine released during parenteral nutrition. JPEN J Parenter Enteral Nutr 28: 163-168
43. Forrest EH et al. (2002) Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha. Liver 22: 317-320
44. Trauner M et al. (1999) Inflammation-induced cholestasis. J Gastroenterol Hepatol 14: 946-959
45. Crawford JM and Boyer JL (1998) Clinicopathology conferences: inflammation-induced cholestasis. Hepatology 28: 253-260
46. Trauner M et al. (1998) Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 101: 2092-2100
47. Ghose R et al. (2004) Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2: 4
48. Li D et al. (2002) Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 277: 31416-31422
49. Green RM (1996) Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111: 193-198
50. Denson LA et al. (2000) Interleukin-1 beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 275: 8835-8843
51. Lavoie JC et al. (2005) Reduced bile flow associated with parenteral nutrition is independent of oxidant load and parenteral multivitamins. J Pediatr Gastroenterol Nutr 4l: 108-114
52. Zlotkin SH and Anderson GH (1982) The development of cystathionase activity during the first year of life. Pediatr Res 16: 65-68
53. Cooke RJ et al. (1984) Effect of taurine supplementation on hepatic function during short-term parenteral nutrition in the premature infant. J Pediatr Gastroenterol Nutr 3: 234-238
54. Guertin F et al. (1991) Effect of taurine on total parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr 15: 247-251
55. Spencer AU et al. (2005) Pediatric short bowel syndrome: redefining predictors of success. Ann Surg 242: 403-409
56. Moreno A et al. (1994) Aluminum in the neonate related to parenteral nutrition. Acta Paediatr 83: 25-29
57. Rabinow, BE et al (1989) Aluminum in parenteral products: analysis, reduction, and implications for pediatric TPN. J Parenter Sci Technol 43: 132-139
58. Moukarzel AA et al. (1992) Excessive chromium intake in children receiving total parenteral nutrition. Lancet 339: 385-388
59. Bougle D et al. (1993) Chromium and parenteral nutrition in children. J Pediatr Gastroenterol Nutr 17: 72-74
60. Kafritsa Y et al. (1998) Long-term outcome of brain manganese deposition in patients on home parenteral nutrition. Arch Dis Child 79: 263-265
61. Sheldon GF et al. (1978) Hepatic dysfunction during hyperalimentation. Arch Surg 113: 504-508
62. Mashima Y (1979) Effect of calorie overload on puppy livers during parenteral nutrition. JPEN J Parenter Enteral Nutr 3: 139-145
63. Vileisis RA et al. (1980) Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: Effect of protein intake. J Pediatr 96: 893-897
64. Graham MF (1984) Inhibition of bile flow in the isolated perfused rat liver by a synthetic parenteral amino acid mixture: Associated net amino acid fluxes. Hepatology 4: 69-73
65. Shenai JP and Borum PR (1984) Tissue carnitine reserves of newborn infants. Pediatr Res 118: 679-682
66. Bowyer BA et al. (1988) L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations. Gastroenterology 94: 434-438
67. Buchman AL et al. (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: Proof of a human choline requirement: A placebo-controlled trial. JPEN J Parenter Enteral Nutr 25: 260-268
68. Cavicchi M et al. (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132: 525-532
69. Colomb V et al. (2000) Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 24: 345-350
70. Carter BA et al. (2006) Soy lipid-derived stigmasterol (Stig) antagonizes bile acid (BA)-activation of the FXR dependent BA sinusoidal efflux pump genes, OSTα/β, in primary mouse hepatocytes and HepG2cells [abstract #69). J Pediatr Gastroenterol Nutr 43: E35
71. Carter BA et al. (2005) Soy-lipid derived stigmasterol suppresses FXR target genes BSEP and FGF-19, in human hepatoblastoma cells-potential role in total parenteral nutrition-associated cholestasis (TPNAC) [abstract #190]. J Pediatr Gastroenterol Nutr 4l: 552
72. Clayton PT et al. (1993) Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 105: 1806-1813
73. Gura KM et al. (2006) Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management. Pediatrics 118 e197-e201
74. Tezuke Y et al. (2004) Hepatic P-glycoprotein changes with total parenteral nutrition administration. JPEN J Parenter Enteral Nutr 28: 1-6
75. Tazuke Y (2004) Effects of lipid administration on liver apoptotic signals in a mouse model of total parenteral nutrition (TPN). Pediatr Surg Int 20: 224-228
76. Javid PJ et al. (2005) The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg 40: 1446-1453
77. Beuers U (2006) Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 3: 318-328
78. Gunsar C et al. (2002) The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: An experimental study. Hepatogastroenterology 49: 497-500
79. De Marco G et al. (2006) Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 24, 387-394
80. Beau P et al. (1994) Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 20: 240-244
81. Lindor KD and Burnes J (1991) Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis: A case report. Gastroenterology 101: 250-253
82. Spagnuolo MI et al. (1996) Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: A pilot study. Gastroenterology 111: 716-719
83. Tsai S et al. (2005) Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. J Pediatr Surg 40: 263-267
84. Teitelbaum DH et al. (2005) Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis. Pediatrics 115: 1332-1340
85. Heubi JE et al. (2002) Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr 141: 237-242
86. Barshes NR (2006) Isolated orthotopic liver transplantation for parenteral nutrition-associated liver injury. JPEN J Parenter Enteral Nutr 30: 526-629